Three-dimensional Models: a Novel Approach for Lymphoma Research

Overview

Journal J Cancer Res Clin Oncol

Specialty Oncology

Date 2022 Jan 29

PMID 35091834

Authors

Maura Rossi

Francesco Alviano

Simona Righi

Elena Sabattini

Claudio Agostinelli

Affiliations

Soon will be listed here.

Abstract

Purpose: Three dimensional (3D) "in vitro" models are progressively being applied to investigate tumor cell biology and the interaction of cancer cells with tumor microenvironment under conditions more similar and realistic to "in vivo" behavior than standard bidimensional (2D) cultures.

Methods: In the last years, different methods have been developed to create spheroids and organoids and each technique has advantages and limitations also based on individual needs and cell types used. This review offers an overview of methodologies used for 3D systems: scaffold-free and scaffold-based methods up to bioreactors and organ-on-chip models.

Results: The principal goal for researchers is to select the 3D system that best suits their needs and that reflects the tumor model they want to study. A large chapter is dedicated to the application of these models to lymphomas' study, a neoplasm still little explored in the 3D field.

Conclusion: These innovative and advanced models may represent new tools for cancer research and pre-clinical studies of new therapies in the perspective of precision medicine.

Citing Articles

In Vitro 3D Models of Haematological Malignancies: Current Trends and the Road Ahead?.

Mattioda C, Voena C, Ciardelli G, Mattu C Cells. 2025; 14(1.

PMID: 39791739 PMC: 11720277. DOI: 10.3390/cells14010038.

Development of Hemispherical 3D Models of Human Brain and B Cell Lymphomas Using On-Chip Cell Dome System.

Kazama R, Ishikawa R, Sakai S Bioengineering (Basel). 2025; 11(12.

PMID: 39768123 PMC: 11727638. DOI: 10.3390/bioengineering11121303.

Patient-derived follicular lymphoma spheroids recapitulate lymph node signaling and immune profile uncovering galectin-9 as a novel immunotherapeutic target.

Dobano-Lopez C, Valero J, Araujo-Ayala F, Nadeu F, Gava F, Faria C Blood Cancer J. 2024; 14(1):75.

PMID: 38697976 PMC: 11636880. DOI: 10.1038/s41408-024-01041-7.

Review on new approach methods to gain insight into the feto-maternal interface physiology.

Menon R, Muglia L, Levin L Front Med (Lausanne). 2023; 10:1304002.

PMID: 38098843 PMC: 10720461. DOI: 10.3389/fmed.2023.1304002.

Patient-derived lymphoma spheroids integrating immune tumor microenvironment as preclinical follicular lymphoma models for personalized medicine.

Faria C, Gava F, Gravelle P, Valero J, Dobano-Lopez C, Van Acker N J Immunother Cancer. 2023; 11(10).

PMID: 37899130 PMC: 10619028. DOI: 10.1136/jitc-2023-007156.

References

Ahmed E . Hydrogel: Preparation, characterization, and applications: A review. J Adv Res. 2015; 6(2):105-21. PMC: 4348459. DOI: 10.1016/j.jare.2013.07.006. View

Andersen T, Auk-Emblem P, Dornish M . 3D Cell Culture in Alginate Hydrogels. Microarrays (Basel). 2016; 4(2):133-61. PMC: 4996398. DOI: 10.3390/microarrays4020133. View

Baker B, Chen C . Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues. J Cell Sci. 2012; 125(Pt 13):3015-24. PMC: 3434846. DOI: 10.1242/jcs.079509. View

Birgersdotter A, Baumforth K, Porwit A, Sundblad A, Falk K, Wei W . Three-dimensional culturing of the Hodgkin lymphoma cell-line L1236 induces a HL tissue-like gene expression pattern. Leuk Lymphoma. 2007; 48(10):2042-53. DOI: 10.1080/10428190701573190. View

Breslin S, ODriscoll L . Three-dimensional cell culture: the missing link in drug discovery. Drug Discov Today. 2012; 18(5-6):240-9. DOI: 10.1016/j.drudis.2012.10.003. View

Caicedo-Carvajal C, Liu Q, Remache Y, Goy A, Suh K . Cancer Tissue Engineering: A Novel 3D Polystyrene Scaffold for In Vitro Isolation and Amplification of Lymphoma Cancer Cells from Heterogeneous Cell Mixtures. J Tissue Eng. 2011; 2011:362326. PMC: 3168765. DOI: 10.4061/2011/362326. View

Candini O, Grisendi G, Foppiani E, Brogli M, Aramini B, Masciale V . A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology. Sci Rep. 2019; 9(1):7154. PMC: 6509120. DOI: 10.1038/s41598-019-43613-9. View

Cayrol F, Diaz Flaque M, Fernando T, Yang S, Sterle H, Bolontrade M . Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells. Blood. 2014; 125(5):841-51. PMC: 4311229. DOI: 10.1182/blood-2014-07-587337. View

Chaudhuri O, Koshy S, da Cunha C, Shin J, Verbeke C, Allison K . Extracellular matrix stiffness and composition jointly regulate the induction of malignant phenotypes in mammary epithelium. Nat Mater. 2014; 13(10):970-8. DOI: 10.1038/nmat4009. View

10.

Chitcholtan K, Asselin E, Parent S, Sykes P, Evans J . Differences in growth properties of endometrial cancer in three dimensional (3D) culture and 2D cell monolayer. Exp Cell Res. 2012; 319(1):75-87. DOI: 10.1016/j.yexcr.2012.09.012. View

11.

Clevers H . Modeling Development and Disease with Organoids. Cell. 2016; 165(7):1586-1597. DOI: 10.1016/j.cell.2016.05.082. View

12.

Cui X, Hartanto Y, Zhang H . Advances in multicellular spheroids formation. J R Soc Interface. 2017; 14(127). PMC: 5332573. DOI: 10.1098/rsif.2016.0877. View

13.

Decaup E, Jean C, Laurent C, Gravelle P, Fruchon S, Capilla F . Anti-tumor activity of obinutuzumab and rituximab in a follicular lymphoma 3D model. Blood Cancer J. 2013; 3:e131. PMC: 3763386. DOI: 10.1038/bcj.2013.32. View

14.

Decaup E, Rossi C, Gravelle P, Laurent C, Bordenave J, Tosolini M . A Tridimensional Model for NK Cell-Mediated ADCC of Follicular Lymphoma. Front Immunol. 2019; 10:1943. PMC: 6702952. DOI: 10.3389/fimmu.2019.01943. View

15.

Eng C . Microenvironmental protection in diffuse large-B-cell lymphoma. N Engl J Med. 2008; 359(22):2379-81. DOI: 10.1056/NEJMe0808409. View

16.

Fan H, Demirci U, Chen P . Emerging organoid models: leaping forward in cancer research. J Hematol Oncol. 2019; 12(1):142. PMC: 6936115. DOI: 10.1186/s13045-019-0832-4. View

17.

Foxall R, Narang P, Glaysher B, Hub E, Teal E, Coles M . Developing a 3D B Cell Lymphoma Culture System to Model Antibody Therapy. Front Immunol. 2021; 11:605231. PMC: 7897703. DOI: 10.3389/fimmu.2020.605231. View

18.

Gravelle P, Jean C, Valleron W, Laurent G, Fournie J . Innate predisposition to immune escape in follicular lymphoma cells. Oncoimmunology. 2012; 1(4):555-556. PMC: 3382883. DOI: 10.4161/onci.19365. View

19.

Gravelle P, Jean C, Familiades J, Decaup E, Blanc A, Bezombes-Cagnac C . Cell growth in aggregates determines gene expression, proliferation, survival, chemoresistance, and sensitivity to immune effectors in follicular lymphoma. Am J Pathol. 2013; 184(1):282-95. DOI: 10.1016/j.ajpath.2013.09.018. View

20.

Hirschhaeuser F, Menne H, Dittfeld C, West J, Mueller-Klieser W, Kunz-Schughart L . Multicellular tumor spheroids: an underestimated tool is catching up again. J Biotechnol. 2010; 148(1):3-15. DOI: 10.1016/j.jbiotec.2010.01.012. View